Comparison of lymphovenous anastomosis and vascularized lymph node transfer in lymphedema treatment – a literature review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F25%3A00082356" target="_blank" >RIV/00159816:_____/25:00082356 - isvavai.cz</a>

Výsledek na webu

<a href="https://acta-chirurgiae-plasticae.com/archive/2025/1-2025/comparison-of-lymphovenous-anastomosis-and-vascularized-lymph-node-transfer-in-lymphedema-treatment-a-literature-review/" target="_blank" >https://acta-chirurgiae-plasticae.com/archive/2025/1-2025/comparison-of-lymphovenous-anastomosis-and-vascularized-lymph-node-transfer-in-lymphedema-treatment-a-literature-review/</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.48095/ccachp202542" target="_blank" >10.48095/ccachp202542</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Comparison of lymphovenous anastomosis and vascularized lymph node transfer in lymphedema treatment – a literature review

Popis výsledku v původním jazyce

Background: Lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) are both accepted microsurgical treatment optionsfor lymphedema. This article summarises and analyses recent data on outcomes associated with LVA and VLNT for lymphedema treatment atvarying degrees of severity. Methods: Literature research was conducted in the PubMed and Embase Ovid database to extract articles publishedthrough March 2024. The included studies report data on objective and subjective improvement in lymphedema after physiological surgicalprocedures as LVA and VLNT. Extracted data comprised number of patients, affected limbs, staging of the disease,duration of the followup period,objective and subjective improvement and percentage of discontinuation of compression garments. Results: A total of 23 articles were includedin this article, representing 1,944 patients suffering from either primary or secondary lymphedema. The lymphedema stages were classified byclassification of International Society of Lymphedema (ISL stage) or Campisi stage and range from stage I to III, as well as prophylactic indicationfor surgery. The follow-up duration ranged from 3 months to 8 years. Objective improvement was achieved in 82.76- 100% and measured incircumferential reduction rate and reduction of cellulitis episodes. In 80- 100% of the patient&apos;s subjective improvement was seen, which wasmeasured in quality of life and personal feedback. The percentage of patients able to discontinue the use of compression garments ranges from0 to 100%, while others were able to reduce the total time of wearing. Conclusion: LVA and VLNT are both safe and effective techniques for thesurgical treatment of lymphedema in several stages. LVA should be preferred if the lymph vessels preserved its patency, otherwise VLNT mightbe the therapy of choice. Combinations of various procedures with an appropriate postoperative treatment plan might lead to improved patientoutcomes.

Název v anglickém jazyce

Comparison of lymphovenous anastomosis and vascularized lymph node transfer in lymphedema treatment – a literature review

Popis výsledku anglicky

Background: Lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) are both accepted microsurgical treatment optionsfor lymphedema. This article summarises and analyses recent data on outcomes associated with LVA and VLNT for lymphedema treatment atvarying degrees of severity. Methods: Literature research was conducted in the PubMed and Embase Ovid database to extract articles publishedthrough March 2024. The included studies report data on objective and subjective improvement in lymphedema after physiological surgicalprocedures as LVA and VLNT. Extracted data comprised number of patients, affected limbs, staging of the disease,duration of the followup period,objective and subjective improvement and percentage of discontinuation of compression garments. Results: A total of 23 articles were includedin this article, representing 1,944 patients suffering from either primary or secondary lymphedema. The lymphedema stages were classified byclassification of International Society of Lymphedema (ISL stage) or Campisi stage and range from stage I to III, as well as prophylactic indicationfor surgery. The follow-up duration ranged from 3 months to 8 years. Objective improvement was achieved in 82.76- 100% and measured incircumferential reduction rate and reduction of cellulitis episodes. In 80- 100% of the patient&apos;s subjective improvement was seen, which wasmeasured in quality of life and personal feedback. The percentage of patients able to discontinue the use of compression garments ranges from0 to 100%, while others were able to reduce the total time of wearing. Conclusion: LVA and VLNT are both safe and effective techniques for thesurgical treatment of lymphedema in several stages. LVA should be preferred if the lymph vessels preserved its patency, otherwise VLNT mightbe the therapy of choice. Combinations of various procedures with an appropriate postoperative treatment plan might lead to improved patientoutcomes.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

30212 - Surgery

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Acta Chirurgiae Plasticae

ISSN

0001-5423

e-ISSN

1805-4404

Svazek periodika

67

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

13

Strana od-do

1-13

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-105009657996